Sustained Release Injectables Market Report

Global and Region Sustained Release Injectables Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：197
  • REPORT CODE：GMM998137
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sustained Release Injectables market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sustained Release Injectablesmarket, defines the market attractiveness level of Sustained Release Injectables market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sustained Release Injectables industry, describes the types of Sustained Release Injectables market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sustained Release Injectables market and the development prospects and opportunities of Sustained Release Injectables industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sustained Release Injectables market in Chapter 13.

    By Player:

    • Camurus

    • Aurobindo

    • Novartis

    • Avadel

    • Biomarin

    • AstraZeneca

    • Alkermes

    • Eli Lilly

    • Sanofi

    • Critical Pharmaceuticals

    • Roche

    • Ascendis Pharma

    • Amylin

    • Taiwan Liposome Company

    By Type:

    • Naltrexone

    • Exenatide

    • Estradiol

    • Other

    By End-User:

    • Diabetes

    • Leukemia

    • Acromegaly

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sustained Release Injectables Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sustained Release Injectables Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sustained Release Injectables Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sustained Release Injectables Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sustained Release Injectables Market Analysis and Outlook to 2022

    • 7.1 Global Sustained Release Injectables Consumption (2017-2022)

    • 7.2 United States Sustained Release Injectables Consumption (2017-2022)

    • 7.3 Europe Sustained Release Injectables Consumption (2017-2022)

    • 7.4 China Sustained Release Injectables Consumption (2017-2022)

    • 7.5 Japan Sustained Release Injectables Consumption (2017-2022)

    • 7.6 India Sustained Release Injectables Consumption (2017-2022)

    • 7.7 South Korea Sustained Release Injectables Consumption (2017-2022)

    8 Region and Country-wise Sustained Release Injectables Market Analysis and Outlook to 2028

    • 8.1 Global Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.2 United States Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.3 Europe Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.4 China Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.5 Japan Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.6 India Sustained Release Injectables Consumption Forecast (2022-2028)

    • 8.7 South Korea Sustained Release Injectables Consumption Forecast (2022-2028)

    9 Global Sustained Release Injectables Market Outlook by Types and Applications to 2022

    • 9.1 Global Sustained Release Injectables Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Naltrexone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Exenatide Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Estradiol Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sustained Release Injectables Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Leukemia Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Acromegaly Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Sustained Release Injectables Market Outlook by Types and Applications to 2028

    • 10.1 Global Sustained Release Injectables Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Exenatide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Estradiol Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sustained Release Injectables Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sustained Release Injectables Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sustained Release Injectables Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sustained Release Injectables Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sustained Release Injectables Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sustained Release Injectables Market Competitive Analysis

    • 14.1 Camurus

      • 14.1.1 Camurus Company Details

      • 14.1.2 Camurus Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Camurus Sustained Release Injectables Product and Service

    • 14.2 Aurobindo

      • 14.2.1 Aurobindo Company Details

      • 14.2.2 Aurobindo Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Aurobindo Sustained Release Injectables Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Sustained Release Injectables Product and Service

    • 14.4 Avadel

      • 14.4.1 Avadel Company Details

      • 14.4.2 Avadel Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Avadel Sustained Release Injectables Product and Service

    • 14.5 Biomarin

      • 14.5.1 Biomarin Company Details

      • 14.5.2 Biomarin Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Biomarin Sustained Release Injectables Product and Service

    • 14.6 AstraZeneca

      • 14.6.1 AstraZeneca Company Details

      • 14.6.2 AstraZeneca Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca Sustained Release Injectables Product and Service

    • 14.7 Alkermes

      • 14.7.1 Alkermes Company Details

      • 14.7.2 Alkermes Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Alkermes Sustained Release Injectables Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Sustained Release Injectables Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Sustained Release Injectables Product and Service

    • 14.10 Critical Pharmaceuticals

      • 14.10.1 Critical Pharmaceuticals Company Details

      • 14.10.2 Critical Pharmaceuticals Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Critical Pharmaceuticals Sustained Release Injectables Product and Service

    • 14.11 Roche

      • 14.11.1 Roche Company Details

      • 14.11.2 Roche Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Roche Sustained Release Injectables Product and Service

    • 14.12 Ascendis Pharma

      • 14.12.1 Ascendis Pharma Company Details

      • 14.12.2 Ascendis Pharma Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Ascendis Pharma Sustained Release Injectables Product and Service

    • 14.13 Amylin

      • 14.13.1 Amylin Company Details

      • 14.13.2 Amylin Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Amylin Sustained Release Injectables Product and Service

    • 14.14 Taiwan Liposome Company

      • 14.14.1 Taiwan Liposome Company Company Details

      • 14.14.2 Taiwan Liposome Company Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Taiwan Liposome Company Sustained Release Injectables Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sustained Release Injectables

    • Figure Sustained Release Injectables Picture

    • Table Global Sustained Release Injectables Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sustained Release Injectables Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sustained Release Injectables Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sustained Release Injectables Consumption by Country (2017-2022)

    • Figure United States Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Table Europe Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Figure China Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Figure Japan Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Figure India Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sustained Release Injectables Consumption and Growth Rate (2017-2022)

    • Figure Global Sustained Release Injectables Consumption Forecast by Country (2022-2028)

    • Figure United States Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sustained Release Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Naltrexone Consumption and Growth Rate (2017-2022)

    • Figure Global Exenatide Consumption and Growth Rate (2017-2022)

    • Figure Global Estradiol Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Acromegaly Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Exenatide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Estradiol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sustained Release Injectables Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sustained Release Injectables Export by Region (Top 5 Countries) (2017-2028)

    • Table Camurus (Foundation Year, Company Profile and etc.)

    • Table Camurus Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Camurus Sustained Release Injectables Product and Service

    • Table Aurobindo (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Sustained Release Injectables Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Sustained Release Injectables Product and Service

    • Table Avadel (Foundation Year, Company Profile and etc.)

    • Table Avadel Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Avadel Sustained Release Injectables Product and Service

    • Table Biomarin (Foundation Year, Company Profile and etc.)

    • Table Biomarin Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomarin Sustained Release Injectables Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Sustained Release Injectables Product and Service

    • Table Alkermes (Foundation Year, Company Profile and etc.)

    • Table Alkermes Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alkermes Sustained Release Injectables Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Sustained Release Injectables Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Sustained Release Injectables Product and Service

    • Table Critical Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Critical Pharmaceuticals Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Critical Pharmaceuticals Sustained Release Injectables Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Sustained Release Injectables Product and Service

    • Table Ascendis Pharma (Foundation Year, Company Profile and etc.)

    • Table Ascendis Pharma Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascendis Pharma Sustained Release Injectables Product and Service

    • Table Amylin (Foundation Year, Company Profile and etc.)

    • Table Amylin Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amylin Sustained Release Injectables Product and Service

    • Table Taiwan Liposome Company (Foundation Year, Company Profile and etc.)

    • Table Taiwan Liposome Company Sustained Release Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taiwan Liposome Company Sustained Release Injectables Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US